A S Davison1,2, B Norman3, A M Milan4,3, A T Hughes4,3, M Khedr4,3, J Rovensky5, J A Gallagher3, L R Ranganath4,3. 1. Department of Clinical Biochemistry and Metabolic Medicine, Liverpool Clinical Laboratories, Royal Liverpool University Hospitals Trust, Liverpool, UK. andrew.davison@rlbuht.nhs.uk. 2. Bone and Joint Research Group, Musculoskeletal Biology, University of Liverpool, Liverpool, UK. andrew.davison@rlbuht.nhs.uk. 3. Bone and Joint Research Group, Musculoskeletal Biology, University of Liverpool, Liverpool, UK. 4. Department of Clinical Biochemistry and Metabolic Medicine, Liverpool Clinical Laboratories, Royal Liverpool University Hospitals Trust, Liverpool, UK. 5. National Institute of Rheumatic Diseases, Piešťany, Slovakia.
Abstract
BACKGROUND: One of the major metabolic consequences of using nitisinone to treat patients with alkaptonuria is that circulating tyrosine concentrations increase. As tyrosine is required for the biosynthesis of catecholamine neurotransmitters, it is possible that their metabolism is altered as a consequence. Herein we report the 24-h urinary excretion of normetadrenaline (NMA), metadrenaline (MA), 3-methoxytyramine (3-MT) (catecholamine metabolites) and 5-hydroxyindole acetic acid (5-HIAA, metabolite of serotonin) in a cohort of AKU patients before and after a 4-week treatment trial with nitisinone. MATERIALS AND METHODS: 24 h urinary excretions of NMA, MA, 3-MT and 5-HIAA were determined by liquid chromatography tandem mass spectrometry. Interassay coefficient of variation was <10% for all analytes measured, at all concentrations tested. RESULTS: Urine samples were assayed at baseline (pre-nitisinone, n = 36) and 4 weeks later; 7 received no nitisinone (4 male, mean age (±SD) 46.3 (16.4) years), and 29 received a daily dose of nitisinone [1 mg (n = 7, 6 male, mean age 45.9 (10.9) years), 2 mg (n = 8, 5 male, mean age 43.9 (13.7) years), 4 mg (n = 8, 5 male, mean age 47.3 (10.7) years) and 8 mg (n = 6, 4 male, mean age 53.8 (8.3) years)]. 3-MT concentrations increase significantly (p < 0.01, at all doses) following nitisinone therapy but not in a dose-dependent manner. NMA concentrations decreased (p < 0.05, at all doses) following nitisinone therapy at all doses. 5-HIAA concentrations decreased following nitisinone therapy and were significantly lower at a daily dose of 8 mg only (p < 0.05). CONCLUSIONS: This study shows that catecholamine and serotonin metabolism is altered by treatment with nitisinone.
BACKGROUND: One of the major metabolic consequences of using nitisinone to treat patients with alkaptonuria is that circulating tyrosine concentrations increase. As tyrosine is required for the biosynthesis of catecholamine neurotransmitters, it is possible that their metabolism is altered as a consequence. Herein we report the 24-h urinary excretion of normetadrenaline (NMA), metadrenaline (MA), 3-methoxytyramine (3-MT) (catecholamine metabolites) and 5-hydroxyindole acetic acid (5-HIAA, metabolite of serotonin) in a cohort of AKUpatients before and after a 4-week treatment trial with nitisinone. MATERIALS AND METHODS: 24 h urinary excretions of NMA, MA, 3-MT and 5-HIAA were determined by liquid chromatography tandem mass spectrometry. Interassay coefficient of variation was <10% for all analytes measured, at all concentrations tested. RESULTS: Urine samples were assayed at baseline (pre-nitisinone, n = 36) and 4 weeks later; 7 received no nitisinone (4 male, mean age (±SD) 46.3 (16.4) years), and 29 received a daily dose of nitisinone [1 mg (n = 7, 6 male, mean age 45.9 (10.9) years), 2 mg (n = 8, 5 male, mean age 43.9 (13.7) years), 4 mg (n = 8, 5 male, mean age 47.3 (10.7) years) and 8 mg (n = 6, 4 male, mean age 53.8 (8.3) years)]. 3-MT concentrations increase significantly (p < 0.01, at all doses) following nitisinone therapy but not in a dose-dependent manner. NMA concentrations decreased (p < 0.05, at all doses) following nitisinone therapy at all doses. 5-HIAA concentrations decreased following nitisinone therapy and were significantly lower at a daily dose of 8 mg only (p < 0.05). CONCLUSIONS: This study shows that catecholamine and serotonin metabolism is altered by treatment with nitisinone.
Authors: Megan A Hillgartner; Sarah B Coker; Ashton E Koenig; Marissa E Moore; Elizabeth Barnby; Gordon G MacGregor Journal: J Inherit Metab Dis Date: 2016-06-06 Impact factor: 4.982
Authors: Corinne De Laet; Vanessa Terrones Munoz; Jaak Jaeken; Baudouin François; Dietbrandt Carton; Etienne M Sokal; Bernard Dan; Philippe J Goyens Journal: Dev Med Child Neurol Date: 2011-07-11 Impact factor: 5.449
Authors: Chanika Phornphutkul; Wendy J Introne; Monique B Perry; Isa Bernardini; Mark D Murphey; Diana L Fitzpatrick; Paul D Anderson; Marjan Huizing; Yair Anikster; Lynn H Gerber; William A Gahl Journal: N Engl J Med Date: 2002-12-26 Impact factor: 91.245
Authors: Andrew S Davison; Brendan P Norman; Hazel Sutherland; Anna M Milan; James A Gallagher; Jonathan C Jarvis; Lakshminarayan R Ranganath Journal: Metabolites Date: 2022-05-25
Authors: Brendan P Norman; Andrew S Davison; Juliette H Hughes; Hazel Sutherland; Peter Jm Wilson; Neil G Berry; Andrew T Hughes; Anna M Milan; Jonathan C Jarvis; Norman B Roberts; Lakshminarayan R Ranganath; George Bou-Gharios; James A Gallagher Journal: Genes Dis Date: 2021-02-22
Authors: A S Davison; B P Norman; E A Smith; J Devine; J Usher; A T Hughes; M Khedr; A M Milan; J A Gallagher; L R Ranganath Journal: JIMD Rep Date: 2018-05-13
Authors: A S Davison; N Strittmatter; H Sutherland; A T Hughes; J Hughes; G Bou-Gharios; A M Milan; R J A Goodwin; L R Ranganath; J A Gallagher Journal: Metabolomics Date: 2019-04-29 Impact factor: 4.290
Authors: Andrew S Davison; Brendan P Norman; Gordon A Ross; Andrew T Hughes; Milad Khedr; Anna M Milan; James A Gallagher; Lakshminarayan R Ranganath Journal: JIMD Rep Date: 2019-05-31
Authors: Juliette H Hughes; Peter J M Wilson; Hazel Sutherland; Shirley Judd; Andrew T Hughes; Anna M Milan; Jonathan C Jarvis; George Bou-Gharios; Lakshminarayan R Ranganath; James A Gallagher Journal: J Inherit Metab Dis Date: 2020-01-13 Impact factor: 4.982